Calcein-acetoxymethy ester enhances the antitumor effects of doxorubicin in nonsmall cell lung cancer by regulating the TopBP1/p53RR pathway. [electronic resource]
Producer: 20171206Description: 861-868 p. digitalISSN:- 1473-5741
- A549 Cells
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carrier Proteins -- metabolism
- Cell Line, Tumor
- DNA-Binding Proteins -- metabolism
- Dose-Response Relationship, Drug
- Down-Regulation -- drug effects
- Doxorubicin -- administration & dosage
- Drug Synergism
- Fluoresceins -- administration & dosage
- Humans
- Lung Neoplasms -- drug therapy
- Nuclear Proteins -- metabolism
- Signal Transduction -- drug effects
- Tumor Suppressor Protein p53 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.